Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) EBIT (2016 - 2025)

Historic EBIT for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $42.6 million.

  • Merit Medical Systems' EBIT rose 1436.09% to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.1 million, marking a year-over-year increase of 939.37%. This contributed to the annual value of $155.7 million for FY2024, which is 2561.56% up from last year.
  • According to the latest figures from Q3 2025, Merit Medical Systems' EBIT is $42.6 million, which was up 1436.09% from $46.9 million recorded in Q2 2025.
  • In the past 5 years, Merit Medical Systems' EBIT registered a high of $46.9 million during Q2 2025, and its lowest value of $8.9 million during Q2 2021.
  • Moreover, its 5-year median value for EBIT was $30.4 million (2022), whereas its average is $29.4 million.
  • Its EBIT has fluctuated over the past 5 years, first surged by 2479218.75% in 2021, then soared by 203.28% in 2025.
  • Quarter analysis of 5 years shows Merit Medical Systems' EBIT stood at $21.9 million in 2021, then soared by 38.92% to $30.4 million in 2022, then increased by 10.5% to $33.6 million in 2023, then grew by 8.78% to $36.6 million in 2024, then rose by 16.54% to $42.6 million in 2025.
  • Its EBIT stands at $42.6 million for Q3 2025, versus $46.9 million for Q2 2025 and $41.0 million for Q1 2025.